Radiopharmaceuticals in Nuclear Medicine - Global Market Research and Forecast, 2015-2025

Table of Content

1 EXECUTIVE SUMMARY

2 METHODOLOGY

3 TRENDS AND DRIVERS

• 3.1 Radiopharmaceuticals in Nuclear Medicine Market Size and Trends
• 3.2 Opportunities in Radiopharmaceuticals in Nuclear Medicine
• 3.3 Market Inhibitors

4 MARKET DYNAMICS

• 4.1 Radiopharmaceuticals in Nuclear Medicine Industry Chain
• 4.2 Radiopharmaceuticals in Nuclear Medicine Cost Analysis
• 4.3 Radiopharmaceuticals in Nuclear Medicine Pricing Strategy
• 4.4 Distribution Structure
• 4.5 Enter Strategy

5 MARKET AND TECHNICAL CHALLENGES

• 5.1 Commercialization Stage
• 5.2 Economic Impact
• 5.3 Competitive landscape Overview
• 5.4 Regulatory/Government policy

6 PORTER’S FIVE FORCE ANALYSIS

• 6.1 Threat of New Entrants
• 6.2 Bargaining Power of Suppliers
• 6.3 Bargaining Power of Buyers
• 6.4 Threat of Substitute
• 6.5 Segment Rivalry

7 Value Chain Analysis

• 7.1 Upstream Overview
• 7.2 Companies Distribution
• 7.3 Brand and Processing
• 7.4 Distribution Channel

8 Radiopharmaceuticals in Nuclear Medicine MARKET, BY TYPE

• 8.1 Overview
• 8.2 Market Size & Analysis, By Type
  • 8.2.1 Diagnostic Radiopharmaceuticals
  • 8.2.2 Therapy Radiopharmaceuticals
  • 8.2.3 Enriched Stable Isotopes

9 Global MARKET, BY REGIONS

• 9.1 Global Market Size and Share by Regions
• 9.2 North America Market
  • 9.2.1 US
  • 9.2.1 Canada
  • 9.2.1 Mexico
• 9.3 Europe Market
  • 9.3.1 UK
  • 9.3.2 Sweden
  • 9.3.3 Germany
  • 9.3.4 Spain
  • 9.3.5 Russia
  • 9.3.6 France
  • 9.3.7 Rest of Europe
• 9.4 Asia & Pacific Market
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Korea
  • 9.4.5 Australia
  • 9.4.6 Southeast Asia
  • 9.4.7 Rest of Asia & Pacific
• 9.5 LAMEA Market
  • 9.5.1 Latin America
  • 9.5.2 Middle East
  • 9.5.3 Africa

10 Top Company

• 10.1 Bracco Imaging S.P.A.
  • 10.1.1 Business Overview
  • 10.1.2 Recent Development
• 10.2 Cambridge Isotope Laboratories, Inc.
• 10.3 Cardinal Health, Inc.
• 10.4 Covidien, Plc
• 10.5 Eczacibasi-Monrol
• 10.6 Fujifilm Holdings Corporation
• 10.7 GE Healthcare (Subsidiary Of General Electric Company)
• 10.8 IBA Group
• 10.9 Isotec, Inc. (Sigma-Aldrich)
• 10.10 Lantheus Medical Imaging, Inc.
• 10.11 Nordion, Inc.
• 10.12 Ntp Radioisotopes (Pty), Ltd.
• 10.13 Siemens Healthcare (Subsidiary Of Siemens AG)
• 10.14 Taiyo Nippon Sanso Corporation
• 10.15 Urenco Limited
• 10.16 Rotem Industries, Ltd., Inc.
• 10.17 Australian Nuclear Association And Technology Organization (ANSTO)
• 10.18 Board of Radiation And Isotope Technology (BRIT)
• 10.19 Institute of Atomic Energy Polatom Radioisotope Centre
• 10.20 Institute of Isotopes Co., Ltd.
• 10.21 Institute Of Radioelement (IRE)

11 Market Forecast

• 11.1 Global Market Forecast
• 11.2 Market Forecast by Type
• 11.3 Market Forecast by Region

12 Conclusion